Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Nephros (NEPH) Leases (2019 - 2025)

Nephros has reported Leases over the past 7 years, most recently at $17000.0 for Q4 2025.

  • Quarterly results put Leases at $17000.0 for Q4 2025, down 98.75% from a year ago — trailing twelve months through Dec 2025 was $17000.0 (down 98.75% YoY), and the annual figure for FY2025 was $17000.0, down 98.75%.
  • Leases for Q4 2025 was $17000.0 at Nephros, down from $18000.0 in the prior quarter.
  • Over the last five years, Leases for NEPH hit a ceiling of $1.8 million in Q4 2023 and a floor of $2000.0 in Q1 2024.
  • Median Leases over the past 5 years was $33000.0 (2021), compared with a mean of $487736.8.
  • Peak annual rise in Leases hit 19275.0% in 2024, while the deepest fall reached 99.77% in 2024.
  • Nephros' Leases stood at $590000.0 in 2021, then skyrocketed by 64.75% to $972000.0 in 2022, then skyrocketed by 85.49% to $1.8 million in 2023, then fell by 24.85% to $1.4 million in 2024, then tumbled by 98.75% to $17000.0 in 2025.
  • The last three reported values for Leases were $17000.0 (Q4 2025), $18000.0 (Q3 2025), and $19000.0 (Q2 2025) per Business Quant data.